Craniodiaphyseal dysplasia
Craniodiaphyseal Dysplasia (CDD) is a rare genetic disorder characterized by abnormal bone growth, particularly affecting the skull and facial bones. This condition leads to excessive calcium deposition and thickening of the cranial bones, resulting in a distinctive facial appearance and potential complications due to the compression of cranial nerves and other structures.
Etiology[edit | edit source]
Craniodiaphyseal Dysplasia is believed to be caused by mutations in genes responsible for bone metabolism and growth. The condition is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to manifest the disorder.
Clinical Features[edit | edit source]
Patients with Craniodiaphyseal Dysplasia typically present with:
- Hyperostosis of the cranial bones
- Facial dysmorphism, including a broad nasal bridge and hypertelorism
- Proptosis due to orbital involvement
- Hearing loss and vision impairment due to cranial nerve compression
- Respiratory difficulties from nasal obstruction
Diagnosis[edit | edit source]
The diagnosis of Craniodiaphyseal Dysplasia is primarily based on clinical evaluation and imaging studies. Radiography and CT scans reveal characteristic thickening of the cranial bones. Genetic testing can confirm the diagnosis by identifying mutations associated with the disorder.
Management[edit | edit source]
There is no cure for Craniodiaphyseal Dysplasia, and treatment is primarily supportive. Management strategies include:
- Surgical intervention to relieve pressure on cranial nerves
- Hearing aids for auditory impairment
- Physical therapy to improve mobility and function
- Multidisciplinary care involving specialists such as neurologists, otolaryngologists, and geneticists
Prognosis[edit | edit source]
The prognosis for individuals with Craniodiaphyseal Dysplasia varies depending on the severity of the condition and the presence of complications. Early intervention and comprehensive care can improve quality of life and functional outcomes.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD